Global Sleep Disorders Drug Market Research Report 2018
Sleep Disorders Drug Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the Sleep Disorders Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Sleep Disorders Drug Market;
3.) the North American Sleep Disorders Drug Market;
4.) the European Sleep Disorders Drug Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
The report firstly introduced the Sleep Disorders Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Sleep Disorders Drug Market;
3.) the North American Sleep Disorders Drug Market;
4.) the European Sleep Disorders Drug Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
PART I SLEEP DISORDERS DRUG INDUSTRY OVERVIEW
CHAPTER ONE SLEEP DISORDERS DRUG INDUSTRY OVERVIEW
1.1 Sleep Disorders Drug Definition
1.2 Sleep Disorders Drug Classification Analysis
1.2.1 Sleep Disorders Drug Main Classification Analysis
1.2.2 Sleep Disorders Drug Main Classification Share Analysis
1.3 Sleep Disorders Drug Application Analysis
1.3.1 Sleep Disorders Drug Main Application Analysis
1.3.2 Sleep Disorders Drug Main Application Share Analysis
1.4 Sleep Disorders Drug Industry Chain Structure Analysis
1.5 Sleep Disorders Drug Industry Development Overview
1.5.1 Sleep Disorders Drug Product History Development Overview
1.5.1 Sleep Disorders Drug Product Market Development Overview
1.6 Sleep Disorders Drug Global Market Comparison Analysis
1.6.1 Sleep Disorders Drug Global Import Market Analysis
1.6.2 Sleep Disorders Drug Global Export Market Analysis
1.6.3 Sleep Disorders Drug Global Main Region Market Analysis
1.6.4 Sleep Disorders Drug Global Market Comparison Analysis
1.6.5 Sleep Disorders Drug Global Market Development Trend Analysis
CHAPTER TWO SLEEP DISORDERS DRUG UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA SLEEP DISORDERS DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA SLEEP DISORDERS DRUG MARKET ANALYSIS
3.1 Asia Sleep Disorders Drug Product Development History
3.2 Asia Sleep Disorders Drug Competitive Landscape Analysis
3.3 Asia Sleep Disorders Drug Market Development Trend
CHAPTER FOUR 2013-2018 ASIA SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
4.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
4.3 2013-2018 Sleep Disorders Drug Demand Overview
4.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
4.5 2013-2018 Sleep Disorders Drug Import Export Consumption
4.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
6.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
6.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
6.3 2018-2022 Sleep Disorders Drug Demand Overview
6.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
6.5 2018-2022 Sleep Disorders Drug Import Export Consumption
6.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART III NORTH AMERICAN SLEEP DISORDERS DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN SLEEP DISORDERS DRUG MARKET ANALYSIS
7.1 North American Sleep Disorders Drug Product Development History
7.2 North American Sleep Disorders Drug Competitive Landscape Analysis
7.3 North American Sleep Disorders Drug Market Development Trend
CHAPTER EIGHT 2013-2018 NORTH AMERICAN SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
8.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
8.3 2013-2018 Sleep Disorders Drug Demand Overview
8.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
8.5 2013-2018 Sleep Disorders Drug Import Export Consumption
8.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
10.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
10.3 2018-2022 Sleep Disorders Drug Demand Overview
10.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
10.5 2018-2022 Sleep Disorders Drug Import Export Consumption
10.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART IV EUROPE SLEEP DISORDERS DRUG INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE SLEEP DISORDERS DRUG MARKET ANALYSIS
11.1 Europe Sleep Disorders Drug Product Development History
11.2 Europe Sleep Disorders Drug Competitive Landscape Analysis
11.3 Europe Sleep Disorders Drug Market Development Trend
CHAPTER TWELVE 2013-2018 EUROPE SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
12.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
12.3 2013-2018 Sleep Disorders Drug Demand Overview
12.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
12.5 2013-2018 Sleep Disorders Drug Import Export Consumption
12.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
14.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
14.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
14.3 2018-2022 Sleep Disorders Drug Demand Overview
14.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
14.5 2018-2022 Sleep Disorders Drug Import Export Consumption
14.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART V SLEEP DISORDERS DRUG MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN SLEEP DISORDERS DRUG MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Sleep Disorders Drug Marketing Channels Status
15.2 Sleep Disorders Drug Marketing Channels Characteristic
15.3 Sleep Disorders Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN SLEEP DISORDERS DRUG NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Sleep Disorders Drug Market Analysis
17.2 Sleep Disorders Drug Project SWOT Analysis
17.3 Sleep Disorders Drug New Project Investment Feasibility Analysis
PART VI GLOBAL SLEEP DISORDERS DRUG INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2013-2018 GLOBAL SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
18.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
18.3 2013-2018 Sleep Disorders Drug Demand Overview
18.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
18.5 2013-2018 Sleep Disorders Drug Import Export Consumption
18.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
19.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
19.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
19.3 2018-2022 Sleep Disorders Drug Demand Overview
19.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
19.5 2018-2022 Sleep Disorders Drug Import Export Consumption
19.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL SLEEP DISORDERS DRUG INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE SLEEP DISORDERS DRUG INDUSTRY OVERVIEW
1.1 Sleep Disorders Drug Definition
1.2 Sleep Disorders Drug Classification Analysis
1.2.1 Sleep Disorders Drug Main Classification Analysis
1.2.2 Sleep Disorders Drug Main Classification Share Analysis
1.3 Sleep Disorders Drug Application Analysis
1.3.1 Sleep Disorders Drug Main Application Analysis
1.3.2 Sleep Disorders Drug Main Application Share Analysis
1.4 Sleep Disorders Drug Industry Chain Structure Analysis
1.5 Sleep Disorders Drug Industry Development Overview
1.5.1 Sleep Disorders Drug Product History Development Overview
1.5.1 Sleep Disorders Drug Product Market Development Overview
1.6 Sleep Disorders Drug Global Market Comparison Analysis
1.6.1 Sleep Disorders Drug Global Import Market Analysis
1.6.2 Sleep Disorders Drug Global Export Market Analysis
1.6.3 Sleep Disorders Drug Global Main Region Market Analysis
1.6.4 Sleep Disorders Drug Global Market Comparison Analysis
1.6.5 Sleep Disorders Drug Global Market Development Trend Analysis
CHAPTER TWO SLEEP DISORDERS DRUG UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA SLEEP DISORDERS DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA SLEEP DISORDERS DRUG MARKET ANALYSIS
3.1 Asia Sleep Disorders Drug Product Development History
3.2 Asia Sleep Disorders Drug Competitive Landscape Analysis
3.3 Asia Sleep Disorders Drug Market Development Trend
CHAPTER FOUR 2013-2018 ASIA SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
4.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
4.3 2013-2018 Sleep Disorders Drug Demand Overview
4.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
4.5 2013-2018 Sleep Disorders Drug Import Export Consumption
4.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
6.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
6.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
6.3 2018-2022 Sleep Disorders Drug Demand Overview
6.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
6.5 2018-2022 Sleep Disorders Drug Import Export Consumption
6.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART III NORTH AMERICAN SLEEP DISORDERS DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN SLEEP DISORDERS DRUG MARKET ANALYSIS
7.1 North American Sleep Disorders Drug Product Development History
7.2 North American Sleep Disorders Drug Competitive Landscape Analysis
7.3 North American Sleep Disorders Drug Market Development Trend
CHAPTER EIGHT 2013-2018 NORTH AMERICAN SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
8.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
8.3 2013-2018 Sleep Disorders Drug Demand Overview
8.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
8.5 2013-2018 Sleep Disorders Drug Import Export Consumption
8.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
10.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
10.3 2018-2022 Sleep Disorders Drug Demand Overview
10.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
10.5 2018-2022 Sleep Disorders Drug Import Export Consumption
10.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART IV EUROPE SLEEP DISORDERS DRUG INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE SLEEP DISORDERS DRUG MARKET ANALYSIS
11.1 Europe Sleep Disorders Drug Product Development History
11.2 Europe Sleep Disorders Drug Competitive Landscape Analysis
11.3 Europe Sleep Disorders Drug Market Development Trend
CHAPTER TWELVE 2013-2018 EUROPE SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
12.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
12.3 2013-2018 Sleep Disorders Drug Demand Overview
12.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
12.5 2013-2018 Sleep Disorders Drug Import Export Consumption
12.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE SLEEP DISORDERS DRUG KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
14.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
14.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
14.3 2018-2022 Sleep Disorders Drug Demand Overview
14.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
14.5 2018-2022 Sleep Disorders Drug Import Export Consumption
14.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
PART V SLEEP DISORDERS DRUG MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN SLEEP DISORDERS DRUG MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Sleep Disorders Drug Marketing Channels Status
15.2 Sleep Disorders Drug Marketing Channels Characteristic
15.3 Sleep Disorders Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN SLEEP DISORDERS DRUG NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Sleep Disorders Drug Market Analysis
17.2 Sleep Disorders Drug Project SWOT Analysis
17.3 Sleep Disorders Drug New Project Investment Feasibility Analysis
PART VI GLOBAL SLEEP DISORDERS DRUG INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2013-2018 GLOBAL SLEEP DISORDERS DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2013-2018 Sleep Disorders Drug Capacity Production Overview
18.2 2013-2018 Sleep Disorders Drug Production Market Share Analysis
18.3 2013-2018 Sleep Disorders Drug Demand Overview
18.4 2013-2018 Sleep Disorders Drug Supply Demand and Shortage
18.5 2013-2018 Sleep Disorders Drug Import Export Consumption
18.6 2013-2018 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL SLEEP DISORDERS DRUG INDUSTRY DEVELOPMENT TREND
19.1 2018-2022 Sleep Disorders Drug Capacity Production Overview
19.2 2018-2022 Sleep Disorders Drug Production Market Share Analysis
19.3 2018-2022 Sleep Disorders Drug Demand Overview
19.4 2018-2022 Sleep Disorders Drug Supply Demand and Shortage
19.5 2018-2022 Sleep Disorders Drug Import Export Consumption
19.6 2018-2022 Sleep Disorders Drug Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL SLEEP DISORDERS DRUG INDUSTRY RESEARCH CONCLUSIONS
